|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.98 NGN | 0.00% |
|
+10.00% | +2.06% |
Neimeth International Pharmaceuticals Plc reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was NGN 770.61 million compared to NGN 946.3 million a year ago. Net loss was NGN 1,935.7 million compared to NGN 180.31 million a year ago.
Basic loss per share from continuing operations was NGN 0.45 compared to NGN 0.09 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +2.06% | 6.24M | |
| +26.47% | 664B | |
| +25.44% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +13.40% | 234B | |
| +4.63% | 199B | |
| -10.18% | 196B | |
| -4.04% | 148B |
NEIMETH INTERNATIONAL PHARMACEUTICALS PLC 
